DocDollars

Beone Medicines USA, Inc.

MA · United States · Reporting entity ID 100001453226

Total reported 2019–2025
$25.7M
#270 of 2,960 reporting companies — 0% of all reported industry payments
$3.43M in general payments across 14,507 records, plus $22.3M in research funding across 1,596 records.

How it breaks down

General payments $3,428,886
Research funding $22,319,801

Where this comes from

Figures are from the CMS Open Payments “payments grouped by reporting entity” dataset, queried live. Reporting entities are applicable manufacturers and group purchasing organisations required to report under the Sunshine Act.

Summary

Beone Medicines USA, Inc. reported $25.7M to US doctors and teaching hospitals from 2019 to 2025, ranking #270 of 2,960 reporting companies. 87% of that was research funding and 13% general payments such as consulting, speaking, food and travel. 14,507 general payment records and 1,596 research records were filed.

Common questions about Beone Medicines USA, Inc.

How much has Beone Medicines USA, Inc. paid US doctors?

Beone Medicines USA, Inc. reported $25,748,687 to US physicians and teaching hospitals across the 2019–2025 Open Payments program years: $3,428,886 in general payments, $22,319,801 in research funding.

How does Beone Medicines USA, Inc. rank among drug and device companies?

It ranks #270 of 2,960 reporting entities by total reported value, about 0% of all industry payments in the dataset.

Does a payment from Beone Medicines USA, Inc. mean a doctor did something wrong?

No. Open Payments records transfers of value such as speaking fees, consulting, meals, travel and research funding. The data shows the relationship, not its effect on prescribing or care.